Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma (Q48729441)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

corrigendum / erratum

Corrigendum to "Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma" [Exp. Cell Res. (2017) 269-278].

1 reference

10.1016/J.YEXCR.2017.11.023

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1016/J.YEXCR.2017.11.023

author name string

HaiLong Ruan

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

Xiang Li

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

HongMei Yang

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

ZhengShuai Song

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

JunWei Tong

5

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

Qi Cao

6

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

KeShan Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

Wen Xiao

8

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

HaiBin Xiao

9

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

XuanYu Chen

10

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

GuangHua Xu

11

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

Lin Bao

12

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

ZhiYong Xiong

13

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

ChangFei Yuan

14

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

Lei Liu

15

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

Yan Qu

16

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

WenJun Hu

17

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

YaoYing Gao

18

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

ZeYuan Ru

19

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

Ke Chen

20

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

XiaoPing Zhang

21

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

language of work or name

0 references

publication date

3 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

358

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

269-278

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

Endogenous human microRNAs that suppress breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Differential expression of caveolin-1 in renal neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Critical role of CAV1/caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Resistance to targeted therapy in renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Expression and clinical significance of multidrug resistance proteins in brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Clinicopathological significance of caveolin-1 expression by cancer-associated fibroblasts in lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin-1 promotes tumor growth and metastasis via autophagy inhibition in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Global Gene Expression Profiling and Tissue Microarray Reveal Novel Candidate Genes and Down-Regulation of the Tumor Suppressor Gene CAV1 in Sporadic Vestibular Schwannomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Knockdown of caveolin-1 decreases activity of breast cancer resistance protein (BCRP/ABCG2) and increases chemotherapeutic sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin-1 affects tumor drug resistance in esophageal squamous cell carcinoma by regulating expressions of P-gp and MRP1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

The influence of a caveolin-1 mutant on the function of P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Association of caveolin-1 genotypes with renal cell carcinoma risk in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Impact of caveolin-1 expression on clinicopathological parameters in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin 1 protein expression in renal cell carcinoma predicts survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Global analysis of metastasis-associated gene expression in primary cultures from clinical specimens of clear-cell renal-cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

MicroRNA-124 reduces caveolar density by targeting caveolin-1 in porcine kidney epithelial PK15 cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2017.07.004

7 January 2021

Identifiers

10.1016/J.YEXCR.2017.07.004

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/28684115

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48729441&oldid=2207901189"